COGT

Cogent Biosciences Provides Corporate Updates and Reports First Quarter 2021 Financial Results

Cogent Biosciences Reports Fourth Quarter 2020 and Full Year 2020 Financial Results

Cogent Biosciences Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriter's Option to Purchase Additional Shares

Cogent Biosciences Announces Pricing of Upsized Public Offering of Shares of Common Stock

Cogent Biosciences to Participate in 3rd Annual Evercore ISI HealthCONx Virtual Conference

Cogent Biosciences to Present at Jefferies 2020 Virtual London Healthcare Conference

Edited Transcript of COGT earnings conference call or presentation 12-Mar-20 8:30pm GMT